FDA Inspection 1217115 — University of Wisconsin System Radiopharmaceutical Production Facility
The FDA completed an inspection of University of Wisconsin System Radiopharmaceutical Production Facility on September 7, 2023 in Madison, WI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 7, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Madison, WI (United States)